Loss of ALCAM expression is linked to adverse phenotype and poor prognosis in breast cancer: A TMA-based immunohistochemical study on 2,197 breast cancer patients

Publisher： Spandidos Publications

E-ISSN： 1791-2431|32|6|2628-2634

ISSN： 1021-335X

Source： Oncology Reports, Vol.32, Iss.6, 2014-01, pp. : 2628-2634

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PIK3CA expression in invasive breast cancer: a biomarker of poor prognosis

By Aleskandarany Mohammed  

Breast Cancer Research and Treatment, Vol. 122, Iss. 1, 2010-07 ,pp. : 45-53

Springer Publishing Company

Access to resources Recommend Favorite

Elevated expression of USP22 in correlation with poor prognosis in patients with invasive breast cancer

By Zhang Youxue   Yao Lei   Zhang Xianyu   Ji Hongfei   Wang Lihong   Sun Shanshan   Pang Da  

Journal of Cancer Research and Clinical Oncology, Vol. 137, Iss. 8, 2011-08 ,pp. : 1245-1253

Springer Publishing Company

Access to resources Recommend Favorite

Ki67 as a predictor of poor prognosis in patients with triplenegative breast cancer

By  

Oncology Letters, Vol. 9, Iss. 1, 2015-01 ,pp. : 149-152

Spandidos Publications

Access to resources Recommend Favorite

Glutathione and glutathione peroxidase expression in breast cancer: An immunohistochemical and molecular study

By                

Oncology Reports, Vol. 30, Iss. 3, 2013-01 ,pp. : 1119-1128

Spandidos Publications

Access to resources Recommend Favorite

Integrated gene expression profile predicts prognosis of breast cancer patients

By Li Lian-Fang  

Breast Cancer Research and Treatment, Vol. 113, Iss. 2, 2009-01 ,pp. : 231-237

Springer Publishing Company

Access to resources Recommend Favorite